Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives

Launched by HUASHAN HOSPITAL · Aug 26, 2020

Keywords

ClinConnect Summary

This clinical trial is looking into how managing high blood pressure and other related health risks can affect heart and kidney health in people diagnosed with hypertension. It will involve patients from various medical departments, such as cardiology and nephrology, and aims to gather important information about the best ways to help those with high blood pressure avoid serious health issues.

To be eligible for this study, participants should be adults aged 65 and older who have been diagnosed with high blood pressure, either through measurements taken during their visit or by being on blood pressure medication for at least two weeks before. Unfortunately, younger individuals, those with specific types of secondary high blood pressure, or certain serious health conditions will not be able to participate. If you join the study, you can expect to receive integrated care aimed at managing your blood pressure and other health risks, while contributing to valuable research that may help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine.
• • 2. Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( ≥140 mmHg SBP and/or ≥90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs ≥ 2 weeks.
• • 3. Voluntary participation.
• Exclusion Criteria:
• • 1. Patients aged\< 18 years old.
• • 2. Patients without a definite diagnosis of hypertension(for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension).
• • 3. Patients with a definite diagnosis of secondary hypertension.
• • 4. Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc.
• • 5. Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients.
• • 6. Patients diagnosed with mental abnormalities who are unable to complete the questionnaire.
• • 7. Patients have once participated in this research during this study cycle(to avoid repeated participation).